Literature DB >> 9504870

Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease.

J H O'Keefe1, T M Bateman, R W Ligon, J Case, J Cullom, C Barnhart, J Spertus.   

Abstract

The purpose of this study was to evaluate the outcomes of medical management compared with invasive management for patients with mild or moderate ischemia (non-high-risk) on stress tomographic myocardial perfusion scintigraphy. Of the 1,352 non-high-risk patients, 116 (9%) subsequently were referred for coronary angiography within the first 30 days after the scan; 99 (85%) of this group also underwent early revascularization procedures. The remaining 1,236 patients (91%) with non-high-risk ischemia did not undergo early invasive management. Unadjusted actuarial 3-year rate of cardiac death or nonfatal infarction was significantly better estimated survival in the medically managed group (2%) compared with the invasively managed group (22%), p = 0.0001. Subsequent coronary revascularization procedures during 3-year follow-up were less frequent in the medically managed group (4%) than in the invasively managed group (42%), p = 0.0001. A multivariable analysis identified invasive management strategy (p = 0.0001) as the only correlate of cardiac events during follow-up. In summary, this study showed that patients with non-high-risk ischemia on stress perfusion imaging can be treated safely with a conservative medical management strategy.

Entities:  

Mesh:

Year:  1998        PMID: 9504870     DOI: 10.1016/s1071-3581(98)80007-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  33 in total

Review 1.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

2.  Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations.

Authors:  A V Bruschke; W L Proudfit; F M Sones
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

3.  Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease.

Authors:  M L Ladenheim; B H Pollock; A Rozanski; D S Berman; H M Staniloff; J S Forrester; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

4.  Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology.

Authors:  J l Ritchie; T M Bateman; R O Bonow; M H Crawford; R J Gibbons; R J Hall; R A O'Rourke; A F Parisi; M S Verani
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

5.  Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina.

Authors: 
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

6.  Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment.

Authors:  K A Brown
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

7.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease.

Authors:  D B Mark; L Shaw; F E Harrell; M A Hlatky; K L Lee; J R Bengtson; C B McCants; R M Califf; D B Pryor
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

8.  Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography.

Authors:  C N Bairey; A Rozanski; J Maddahi; K J Resser; D S Berman
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

9.  Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy.

Authors:  S Nishimura; J J Mahmarian; M S Verani
Journal:  J Nucl Med       Date:  1992-09       Impact factor: 10.057

10.  Prognostic utility of increased pulmonary thallium uptake in patients without ischemia.

Authors:  N Zafrir; S T Dahlberg; B J Villegas; J A Leppo
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

View more
  16 in total

1.  Challenges and strategies in the provision of high-quality nuclear cardiology imaging services in office-based cardiology practice.

Authors:  Timothy M Bateman; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

2.  The role of stress myocardial perfusion imaging in the risk stratification of patients with remote myocardial infarction.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

3.  Clinical decision making in patients with stable anginal symptoms: combining functional assessment with morphology to guide treatment.

Authors:  Pier Luigi Pieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Revascularize only for ischemia, especially if left ventricular function is poor.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

5.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

6.  Prognostic characterization of patients with mild coronary artery disease with myocardial perfusion single photon emission computed tomography: validation of an outcomes-based strategy.

Authors:  R Hachamovitch
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

7.  Electrocardiographic changes during vasodilator SPECT myocardial perfusion imaging: does it affect diagnosis or prognosis?

Authors:  Talhat Azemi; Mridula Rai; Purvi Parwani; Sarkis Baghdasarian; Fawad Kazi; Alan W Ahlberg; Giselle Cyr; Deborah Katten; David O'Sullivan; Daniel Fram; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2011-09-23       Impact factor: 5.952

Review 8.  The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?

Authors:  Joe X Xie; David E Winchester; Lawrence M Phillips; Rory Hachamovitch; Daniel S Berman; Ron Blankstein; Marcelo F Di Carli; Todd D Miller; Mouaz H Al-Mallah; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2017-07-27       Impact factor: 5.952

9.  Successful innovation: A time for change?

Authors:  Jeffrey M Dendy; Peter Tilkemeier
Journal:  J Nucl Cardiol       Date:  2016-05-24       Impact factor: 5.952

Review 10.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.